Introduction. - Small intestinal bacterial overgrowth syndrome (SIBOS) has
various clinical and biological presentations. Six observations are describ
ed in this review which is aimed at reporting recent data on SIBOS and prop
osing diagnosis and therapeutic attitudes.
Current knowledge and key points. - Chronic diarrhea, malabsorption syndrom
e and exsudative enteropathy are the main criteria of diagnosis. Breath hyd
rogen testing is commonly performed to confirm diagnosis, with a 78% sensit
ivity and a 89% specificity. The aim of therapy is reparation of malabsorpt
ion consequences, reduction of intestinal bacterial overgrowth, and surgica
l correction of intestinal stasis. in the absence of consensus, norfloxacin
or amoxicillin-clavulinic acid (administered for a mean of 7 to 15 days) s
eem the more appropriate antibiotics. When possible, surgery represents the
primary treatment of SIBOS recurrences.
Future prospects and projects. - Diagnosis of small intestinal bacterial ov
ergrowth syndrome must be evoked on the basis of either surgical or medical
context, i.e., the existence of chronic diarrhea, malabsorption syndrome (
complete or not), and exsudative enteropathy. This review reports essential
factors for diagnosis and treatment. (C) 2001 Editions scientifiques et me
dicales Elsevier SAS.